These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3021382)

  • 1. The pharmacology of agents used in the treatment of pulmonary mycoses.
    Borgers M; Vanden Bossche H; Cauwenbergh G
    Clin Chest Med; 1986 Sep; 7(3):439-52. PubMed ID: 3021382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
    Mary C; Goudard M; Blancard A; Quilici M; Regli P
    Ann Biol Clin (Paris); 1989; 47(9):546-9. PubMed ID: 2558599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the treatment of systemic fungal infections.
    Walsh TJ
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of pulmonary mycoses].
    Schaberg T; Lode H
    Dtsch Med Wochenschr; 1992 Nov; 117(45):1725-9. PubMed ID: 1330477
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
    Högl F; Raab W
    Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine interactions with miconazole and other azole-antimycotics: a case report and review of the literature.
    Horton CM; Freeman CD; Nolan PE; Copeland JG
    J Heart Lung Transplant; 1992; 11(6):1127-32. PubMed ID: 1457436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antifungal susceptibility of fungi isolated from respiratory tract of patients and other sources.
    Chaturvedi VP; Chaturvedi S; Khan ZU; Randhawa HS
    Indian J Chest Dis Allied Sci; 1988; 30(1):36-40. PubMed ID: 3169869
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Odds FC; Cockayne A; Hayward J; Abbott AB
    J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology and pharmacokinetics of traditional systemic antifungal agents.
    Barriere SL
    Pharmacotherapy; 1990; 10(6 ( Pt 3)):134S-140S. PubMed ID: 2075111
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs for treatment of fungal infections.
    Med Lett Drugs Ther; 1992 Feb; 34(864):14-6. PubMed ID: 1310518
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical use of systemic antifungal agents.
    Benson JM; Nahata MC
    Clin Pharm; 1988 Jun; 7(6):424-38. PubMed ID: 3042267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro susceptibility of Cryptococcus strains to 5 antifungal drugs].
    Bava AJ; Negroni R
    Rev Inst Med Trop Sao Paulo; 1989; 31(5):346-50. PubMed ID: 2560840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Candida drugs--the biochemical basis for their activity.
    Vanden Bossche H; Willemsens G; Marichal P
    Crit Rev Microbiol; 1987; 15(1):57-72. PubMed ID: 3319421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Itraconazole in the treatment of deep mycoses].
    Viviani MA; Tortorano AM
    Ann Ist Super Sanita; 1987; 23(4):873-7. PubMed ID: 2837939
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of systemic fungal infections: alternatives to itraconazole.
    Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal infections and their management.
    Graybill JR; Sharkey PK
    Br J Clin Pract Suppl; 1990 Sep; 71():23-31. PubMed ID: 1965416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro evaluation of antifungal agents in the treatment of yeast peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
    Edwards R; Birrell LN; Finch RG
    Chemioterapia; 1987 Feb; 6(1):3-7. PubMed ID: 3829134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of aspergillus lung disease].
    Scholer HJ
    Mykosen; 1983 Apr; 26(4):173-96. PubMed ID: 6306462
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
    Gudewicz TM; Mader JT; Davis CP
    Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.